Lannett Company, Inc. (NYSE:LCI)’s share price reached a new 52-week low on Tuesday . The company traded as low as $12.70 and last traded at $13.40, with a volume of 19338 shares changing hands. The stock had previously closed at $13.45.
A number of research firms recently weighed in on LCI. Oppenheimer reiterated a “hold” rating on shares of Lannett in a research report on Thursday, March 22nd. Zacks Investment Research lowered shares of Lannett from a “hold” rating to a “sell” rating in a research report on Wednesday, April 11th. Finally, ValuEngine lowered shares of Lannett from a “hold” rating to a “sell” rating in a research report on Friday, April 27th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $21.40.
The company has a debt-to-equity ratio of 1.29, a quick ratio of 1.91 and a current ratio of 2.56. The stock has a market cap of $511.29 million, a price-to-earnings ratio of 4.65 and a beta of 2.51.
Lannett (NYSE:LCI) last posted its quarterly earnings data on Monday, May 7th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.76 by $0.04. Lannett had a net margin of 7.01% and a return on equity of 18.64%. The firm had revenue of $174.39 million for the quarter, compared to analyst estimates of $176.51 million. During the same period last year, the firm posted $0.77 EPS. Lannett’s quarterly revenue was up 7.8% on a year-over-year basis. analysts expect that Lannett Company, Inc. will post 3.12 EPS for the current year.
In related news, CEO Timothy C. Crew bought 2,000 shares of the firm’s stock in a transaction on Thursday, May 10th. The shares were bought at an average cost of $14.73 per share, for a total transaction of $29,460.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Patrick G. Lepore bought 25,000 shares of the firm’s stock in a transaction on Friday, May 11th. The shares were bought at an average price of $15.13 per share, for a total transaction of $378,250.00. The disclosure for this purchase can be found here. 14.72% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently modified their holdings of the business. Deutsche Bank AG boosted its position in shares of Lannett by 3.7% during the 4th quarter. Deutsche Bank AG now owns 415,219 shares of the company’s stock worth $9,631,000 after purchasing an additional 14,992 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in shares of Lannett during the 4th quarter worth $223,000. Virtu Financial LLC purchased a new stake in shares of Lannett during the 4th quarter worth $333,000. Cornerstone Capital Management Holdings LLC. boosted its position in shares of Lannett by 190.2% during the 4th quarter. Cornerstone Capital Management Holdings LLC. now owns 65,300 shares of the company’s stock worth $1,514,000 after purchasing an additional 42,800 shares in the last quarter. Finally, Schroder Investment Management Group purchased a new stake in shares of Lannett during the 4th quarter worth $3,506,000. Institutional investors own 98.40% of the company’s stock.
Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages.
Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.